This wiki has undergone a migration to Confluence found Here
Difference between revisions of "May 2016 Pharmacy WGM Agenda"
Jump to navigation
Jump to search
Smrobertson (talk | contribs) (→Agenda) |
Marla albitz (talk | contribs) |
||
(14 intermediate revisions by 3 users not shown) | |||
Line 55: | Line 55: | ||
** Topics from Lee - NCCN Order Templates (to be confirmed with Lee) | ** Topics from Lee - NCCN Order Templates (to be confirmed with Lee) | ||
* Reps to other WG | * Reps to other WG | ||
− | ** Monday Q4 - RCRIM | + | ** Monday Q4 - RCRIM (Jose's PSS) - Tom |
− | ** Tuesday Q2 - O&O | + | ** Tuesday Q2 - O&O - John will check with Hans / FHIR hosting Pharmacy |
− | ** Tuesday Q4 - Patient Care | + | ** Tuesday Q4 - Patient Care - Tom / PHER - John |
− | ** Wednesday Q4 - Patient Care | + | ** Wednesday Q4 - Patient Care (Allergy Value Set) - John & Marla |
− | ** Thursday Q3 - Clinical Statement | + | ** Thursday Q3 - Clinical Statement - Christof/Tom |
* Assign roles for Quarters | * Assign roles for Quarters | ||
* If we have new attendees, review | * If we have new attendees, review | ||
Line 66: | Line 66: | ||
* Hot Topics | * Hot Topics | ||
* Review outstanding FHIR GForge tracker items | * Review outstanding FHIR GForge tracker items | ||
− | ||John||Marla|| | + | ||John||Marla||Nelligan |
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
Line 73: | Line 73: | ||
** [http://gforge.hl7.org/gf/project/desd/scmsvn/?action=browse&path=%2Ftrunk%2FDocuments%2FProjectScopeStatements%2F2016%2FHL7%2520Project%2520Scope%2520Statement%2520v2015.1%2520Allergy%2520and%2520Intolerance%2520Substances%2520Value%2520Sets%25202016%25205%25206.docx&sortby=date&view=log Allergy and Intolerance substances value sets] | ** [http://gforge.hl7.org/gf/project/desd/scmsvn/?action=browse&path=%2Ftrunk%2FDocuments%2FProjectScopeStatements%2F2016%2FHL7%2520Project%2520Scope%2520Statement%2520v2015.1%2520Allergy%2520and%2520Intolerance%2520Substances%2520Value%2520Sets%25202016%25205%25206.docx&sortby=date&view=log Allergy and Intolerance substances value sets] | ||
* Pharmacy FHIR work | * Pharmacy FHIR work | ||
− | || | + | ||Scott||Marla||Nelligan |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
Line 80: | Line 80: | ||
* Action Item List | * Action Item List | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | ||Melva|| | + | ||Melva||John||Nelligan |
|- | |- | ||
− | ||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | + | ||Q4||[[Image:Technical_med.gif|24px]]||CANCELLED Committee Meeting<br> |
* Send rep to RCRIM | * Send rep to RCRIM | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | || | + | ||John||Scott||Nelligan |
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
Line 96: | Line 96: | ||
||Q1||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q1||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | |Melva|| | + | |Melva||John||Nelligan |
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* Joint with FHIR Infrastructure | * Joint with FHIR Infrastructure | ||
+ | ** GForge #8442 | ||
+ | ** How do we apply for an exemption? | ||
+ | *** Additional Instructions issue | ||
+ | *** MedicationOrder - Method exemplar valueset | ||
+ | *** Medication - requirement for all resources to have an Identifier | ||
+ | |||
* Rep to O&O | * Rep to O&O | ||
− | || | + | ||Marla||Melva||Hemon |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | || | + | ||Scott||John||Nelligan |
|- | |- | ||
||Q4||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) | ||Q4||[[Image:Technical_med.gif|24px]]||Joint with PHER (PHER hosting) | ||
− | * Send 1 Rep to Patient Care - PCWG hosting FHIR, ECWG, Vocab and Clinical Genomics - negation modelling + vocab discussions | + | * Send 1 Rep (John) to Patient Care - PCWG hosting FHIR, ECWG, Vocab and Clinical Genomics - negation modelling + vocab discussions |
− | ||NA||NA|| | + | ||NA||NA||Hemon |
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
|. ||||||||||||||||| | |. ||||||||||||||||| | ||
Line 119: | Line 125: | ||
|rowspan="2" align="middle" |AM | |rowspan="2" align="middle" |AM | ||
||Q1||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q1||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
− | * Approval of | + | * Approval of January 2016 WGM Minutes |
* Schedule for Conference calls | * Schedule for Conference calls | ||
* DMP | * DMP | ||
Line 129: | Line 135: | ||
** 3 year plan review | ** 3 year plan review | ||
** Action Item list review | ** Action Item list review | ||
− | || | + | ||John||Melva||Nelligan |
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* Pharmacy Template Work (Kai) | * Pharmacy Template Work (Kai) | ||
− | ||Melva|| | + | ||Melva||John||Nelligan |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q3||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
− | * | + | * Pharmacy FHIR Work |
− | || | + | ||Melva||Marla||Nelligan |
|- | |- | ||
||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* Rep to Patient Care - Allergy Terminology Discussion | * Rep to Patient Care - Allergy Terminology Discussion | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | || | + | ||Marla||Scott||Nelligan |
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
|. ||||||||||||||||| | |. ||||||||||||||||| | ||
Line 154: | Line 160: | ||
||Q1||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q1||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | || | + | ||Marla||Scott||Nelligan |
|- | |- | ||
||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||Q2||[[Image:Technical_med.gif|24px]]||Committee Meeting<br> | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | || | + | ||Melva||Scott||Nelligan |
|- | |- | ||
| rowspan="2" align="middle" |PM | | rowspan="2" align="middle" |PM | ||
Line 164: | Line 170: | ||
* Rep to Clinical Statement | * Rep to Clinical Statement | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | || | + | ||Marla||Scott||Nelligan |
|- | |- | ||
||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||Q4||[[Image:Technical_med.gif|24px]]||Committee Meeting <br> | ||
* Pharmacy FHIR Work | * Pharmacy FHIR Work | ||
− | || | + | ||John||Scott||Nelligan |
|-border="4" cellpadding="8" style="background:#f0f0f0;" | |-border="4" cellpadding="8" style="background:#f0f0f0;" | ||
|. ||||||||||||||||| | |. ||||||||||||||||| |
Latest revision as of 13:13, 11 May 2016
Contents |
Related Links |
Agenda
Icons: